ClinicalTrials.gg
RecruitingNCT07837882PediatricUpdated Sep 24, 2026

Two Different Videolaryngoscopes Were Used İn The Pediatric Patient Group

An observational study in Pediatric and Intubation, sponsored by Samsun University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 2 Years to 10 Years. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by Samsun University · Observational

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
2 Years to 10 Years
Sex
All
01

Study summary

Modern alternatives to traditional laryngoscopes utilize fiber optic or digital technology to project images from the tip of the laryngoscope onto an eyepiece or monitor for improved visualization by the practitioner. Videolaryngoscopes have become an integral part of routine clinical practice and training programs, and a preferred option after failed DL (directional visualization). This study will compare two different videolaryngoscopes in pediatric participants.

Read the detailed description

Based on current literature data, it is suggested that videolaryngoscopy should be considered as the first choice in neonates and infants and that its integration into routine pediatric anesthesia practice may be appropriate. However, it is reported that videolaryngoscopy, compared to direct laryngoscopy, can partially separate the relationship between glottic visualization quality and tracheal tube placement difficulty. Currently, there is no standardized and widely accepted classification system specific to videolaryngoscopy tracheal intubation in pediatric patients. To address this deficiency, the Pediatric Videolaryngoscopic Intubation and Difficult Airway Classification (PeDiAC) score was developed and prospectively defined and validated to determine the difficulty level of pediatric videolaryngoscopy intubation. In this study, the diagnostic performance of the PeDiAC score was evaluated in comparison with the traditionally used Cormack-Lehane classification, and its superiority was investigated. In this planned study, the primary outcome to be evaluated is intubation time, while the secondary outcome is assessed using the PeDiAC score. The aim is to compare the difficulty of intubation between the two devices based on this score. This study aims to determine whether there are differences between the two different videolaryngoscopes in terms of similar clinical outcomes.

02

Conditions studied

  • Pediatric
  • Intubation

Keywords

  • Pediatric
  • videolaryngoscope
  • PEDİAC Score
03

In context

Lead sponsor

Samsun University is the lead sponsor of 89 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

pediatric participant

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 10-40 kg
  • 2-10 years old
  • Elective surgery
  • Requirement for intubation under general anesthesia
  • Expected normal airway

Exclusion criteria

Exclusion Criteria:

  • Difficult airway on preoperative assessment
  • Need for rapid serial intubation
  • History of previous difficult intubation
  • Cervical instability
  • Upper respiratory tract infection within the last 4 weeks
  • Neuromuscular disease
  • History of asthma
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • group E

    In this group, intubation will be performed using an Endolarenx brand videolaryngoscope.

    Device: In this group, intubation will be performed using a Endolarenx brand videolaryngoscope

  • Grup B

    In this group, intubation will be performed using a Besdata brand videolaryngoscope.

    Device: In this group, intubation will be performed using a Besdata brand videolaryngoscope

Interventions

  • DeviceIn this group, intubation will be performed using a Endolarenx brand videolaryngoscope

    In this group, intubation will be performed using a Endolarenx brand videolaryngoscope

  • DeviceIn this group, intubation will be performed using a Besdata brand videolaryngoscope

    In this group, intubation will be performed using a Besdata brand videolaryngoscope

06

What researchers measure

Primary outcomes

  1. intubation time

    The time elapsed from the passage of the laryngoscope blade through the teeth to the detection of end-tidal CO₂.

    Time frame: 2 minutes after induction

Secondary outcomes

  1. PeDiAC Score

    Determining the difficulty level of pediatric videolaryngoscopy intubation.

    Time frame: 1 hour

  2. Cormack-Lehane glottic view scale

    The Cormack-Lehane glottic view classification describes laryngeal visualization during direct laryngoscopy: Grade I indicates a full view of the glottis, Grade II a partial view of the glottis, Grade III visualization of the epiglottis only, and Grade IV visualization of neither the glottis nor the epiglottis.

    Time frame: 1 hour

  3. Successful intubation attempt

    The attempt is considered successful if tracheal intubation is achieved and unsuccessful if intubation fails. Recorded during airway management

    Time frame: 1 hour

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07837882
Lead sponsor
Samsun University
Responsible party
Sponsor
First posted
Sep 24, 2026
Start date
May 1, 2026
Primary completion
Dec 30, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Sep 24, 2026

Study contacts

Hatice Selcuk Kuşderci
Contact
drkusderci@hotmail.com
+905052159896
Ebru Kayıkçi
Contact
ebrukayikci@hotmail.com
+905343605118
Hatice Selcuk Kuşderci
study director · Samsun University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion